Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 1, 1996, Pages 86-91

  George, David ^a   Miniter, Peggy ^a   Andriole, Vincent T ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CYCLOPHOSPHAMIDE; VORICONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; DOSE RESPONSE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TISSUE LEVEL; FEMALE; LEUKOPENIA; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0030071574     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.1.86     Document Type: Article

References (19)

1. Andriole, V. T., P. Miniter, D. George, D. Kordick, and T. F. Patterson. 1992. Animal models: usefulness for studies of fungal pathogenesis and drug efficacy in aspergillosis. Clin Infect. Dis. 14:(Suppl.):S134-S138.
2. Bodey, G. P., and S. Vartivarian. 1989 Aspergillosis. Eur J. Clin. Microbiol. Infect. Dis. 5:413-437.
3. DeGregorio, M. W., W. M. F. Lee, C. A. Linker, R. A. Jacobs, and C. A. Ries. 1982. Fungal infections in patients with acute leukemia. Am. J Med. 73: 543-548
4. Denning, D. W., and D. A. Stevens. 1990. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev. Infect. Dis. 12:1147-1201.
5. George, D., D. Kordick, P. Miniter, T. F. Patterson, and V. T. Andriolc. 1993. Combination therapy in experimental invasive aspergillosis. J. Infect Dis 168:692-698.
6. George, D., P. Miniter, and V. T. Andriole. 1995. Efficacy of UK-109496 (UK), a new azole antifungal agent in experimental invasive aspergillosis (IA), p. 98. In Program and abstracts of the 33rd Annual Meeting of the Infectious Diseases Society of America
7. Graybill, J. R. 1989 New antifungal agents. Eur J Clin. Microbiol. Infect Dis. 5:402-412.
8. Graybill, J. R., and S. R. Kaster. 1984. Experimental murine aspergillosis Comparison of amphotericin B and new polyene antifungal drug, SCH 28191 Am. Rev. Respir. Dis 129:292-295.
9. Hitchcock, C. (Pfizer Central Research). 1994. Personal communication
10. Hostetler, J. S., L. H. Hanson, and D. A. Stevens. 1992. Effect of cyclodextrin on the pharmacology of antifungal oral azoles Antimicrob. Agents Chemother. 36:477-480
11. Meyer, R. D., L. S. Young, D. Armstrong, and B. Yu. 1973 Aspergillosis complicating neoplastic disease. Am. J. Med. 54:6-15.
12. Patterson, T. F., D. George, R. Ingersoll, P. Miniter, and V. T. Andriole. 1991. Efficacy of SCH 39304 in treatment of experimental invasive aspergillosis. Antimicrob. Agents Chemother. 35:1985-1988.
13. Patterson, T. F., D. George, P. Miniter, and V. T. Andriole. 1991 The role of fluconazole in the early treatment and prophylaxis of experimental invasive aspergillosis. J. Infect. Dis. 164:575-580.
14. Patterson, T. F., D. George, P. Miniter, and V. T. Andriole. 1992. Sapcrconazole therapy in a rabbit model of invasive aspergillosis Antimicrob. Agents Chemother 36:2681-2685.
15. Patterson, T. F., P. Miniter, and V. T. Andriole. 1990. Efficacy of fluconazole in experimental invasive asperaillosis. Rev Infect. Dis 12(Suppl. 3):S281-S285.
16. Patterson, T. F., P. Miniter, J. Dijkstra, F. C. Szoka, J. L. Ryan, and V. T. Andriole. 1989. Treatment of experimental invasive aspergillosis with-novel amphotericin B/cholesterol-sulfate complexes J. Infect. Dis. 159:717-724.
17. Patterson, T. F., P. Miniter, J. L. Ryan, and V. T. Andriole. 1988. Effect of immunosupprcssion and amphotericin B on aspcrgillus antigen in an experimental model. J. Infect. Dis 158:415-422.
18. Sabetta, J. R., P. Miniter, and V. T. Andriole. 1985 The diagnosis of invasive aspergillosis by enzyme linked immunosorbent assay for circulating antigen. J. Infect. Dis. 152:946-953.
19. Webb, C. B. (Pfizer-Roerig Division). 1995 Personal communication